Meeting Presentation
- February 2024 - GLP-1 Receptor Agonist Adherence
- December 2023 - Triple Therapy: Opioids, Benzodiazepines, and Skeletal Muscle Relaxants
- September 2023 - Chronic Use of Sedatives/Hypnotics
- June 2023 - Data Presentation: Adherence to Heart Failure Medications
- May 2023 - Data Presentation: Use of Warfarin and Antibiotics
- March 2023 - Data Presentation: Concurrent Use of Opioids and Antipsychotics
- February 2023 - Data Presentation: Appropriate Use of Asthma Controller Medications
- December 2022 - Data Presentation: Metabolic Monitoring with Antipsychotic use in Adolescents
- September 2022 - Data presentation: Opioid Use from Multiple Providers
- June 2022 - Data presentation: Concomitant use of GLP-1 agonists and DPP-4 inhibitors in Type II DM
- May 2022 - Data presentation: Use of Letrozole in Female Members
- April 2022 - Data presentation: Blood Glucose Test Strips in CGM Users
- February 2022 - Data Presentation: Immunologic Therapies for Asthma
- December 2021 - Codeine Use in Pediatric Patients
- September 2021 - Data Presentation: Influenza Vaccination Rates
- September 2021 - Data Presentation: Long-Acting Injectable Antipsychotics
- May 2021 - Data presentation: Codeine Use in the Pediatric Population
- April 2021 - Data presentation: Sublocade Adherence
- February 2021 - Data presentation: Chantix use for Smoking Cessation